| Primary |
| Product Used For Unknown Indication |
79.8% |
| Blood Cholesterol Increased |
4.7% |
| High Density Lipoprotein Decreased |
4.5% |
| Blood Triglycerides Increased |
3.2% |
| Low Density Lipoprotein Increased |
2.4% |
| Hypertension |
1.2% |
| Blood Cholesterol Abnormal |
0.8% |
| Diabetes Mellitus |
0.6% |
| Blood Cholesterol |
0.5% |
| Blood Pressure |
0.3% |
| Cardiac Disorder |
0.2% |
| Gastrooesophageal Reflux Disease |
0.2% |
| High Density Lipoprotein Increased |
0.2% |
| Supplementation Therapy |
0.2% |
| Familial Risk Factor |
0.2% |
| Hypersensitivity |
0.2% |
| High Density Lipoprotein |
0.2% |
| Low Density Lipoprotein |
0.2% |
| Myocardial Infarction |
0.2% |
| Vitamin Supplementation |
0.2% |
|
| Flushing |
38.7% |
| Pruritus |
18.8% |
| Paraesthesia |
9.1% |
| Skin Burning Sensation |
9.1% |
| Rash |
2.7% |
| Myalgia |
2.1% |
| Pruritus Generalised |
2.1% |
| Blood Glucose Increased |
2.0% |
| Urticaria |
1.8% |
| Hot Flush |
1.7% |
| Nausea |
1.7% |
| Wrong Technique In Drug Usage Process |
1.5% |
| Pain In Extremity |
1.4% |
| Feeling Hot |
1.4% |
| Vomiting |
1.2% |
| Insomnia |
1.1% |
| Muscle Spasms |
1.0% |
| Headache |
0.9% |
| Hyperhidrosis |
0.9% |
| Gout |
0.7% |
|
| Secondary |
| Product Used For Unknown Indication |
72.8% |
| High Density Lipoprotein Decreased |
6.4% |
| Blood Triglycerides Increased |
5.0% |
| Blood Cholesterol Increased |
4.7% |
| Low Density Lipoprotein Increased |
4.2% |
| Hypertension |
1.3% |
| Blood Cholesterol Abnormal |
0.9% |
| Diabetes Mellitus |
0.5% |
| Gastrooesophageal Reflux Disease |
0.4% |
| High Density Lipoprotein Abnormal |
0.4% |
| Cardiac Disorder |
0.4% |
| Familial Risk Factor |
0.4% |
| Low Density Lipoprotein Abnormal |
0.4% |
| Blood Cholesterol |
0.4% |
| Coronary Artery Disease |
0.3% |
| Blood Triglycerides Abnormal |
0.3% |
| Low Density Lipoprotein |
0.3% |
| High Density Lipoprotein Increased |
0.3% |
| Blood Triglycerides |
0.3% |
| Myocardial Infarction |
0.3% |
|
| Flushing |
32.7% |
| Pruritus |
21.5% |
| Skin Burning Sensation |
10.4% |
| Paraesthesia |
9.4% |
| Myalgia |
3.3% |
| Rash |
3.3% |
| Blood Glucose Increased |
2.1% |
| Pruritus Generalised |
2.1% |
| Wrong Technique In Drug Usage Process |
2.1% |
| Hyperhidrosis |
1.7% |
| Pain In Extremity |
1.6% |
| Urticaria |
1.6% |
| Insomnia |
1.3% |
| Feeling Hot |
1.2% |
| Drug Ineffective |
1.0% |
| High Density Lipoprotein Decreased |
1.0% |
| Hot Flush |
1.0% |
| Muscle Spasms |
1.0% |
| Nausea |
1.0% |
| Unevaluable Event |
1.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.3% |
| Blood Cholesterol Increased |
6.7% |
| Blood Triglycerides Increased |
6.7% |
| Hypertension |
6.7% |
| Anxiety |
3.3% |
| Blood Iron Decreased |
3.3% |
| Depression |
3.3% |
| Diabetes Mellitus |
3.3% |
| Gastrooesophageal Reflux Disease |
3.3% |
| High Density Lipoprotein |
3.3% |
| Hypothyroidism |
3.3% |
| Prophylaxis |
3.3% |
| Psoriasis |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Vitamin D Decreased |
3.3% |
|
| Diarrhoea |
50.0% |
| Muscle Spasms |
50.0% |
|
| Interacting |
| Product Used For Unknown Indication |
55.6% |
| Blood Cholesterol Increased |
7.4% |
| Blood Triglycerides Increased |
7.4% |
| High Density Lipoprotein Decreased |
7.4% |
| Hypothyroidism |
7.4% |
| Low Density Lipoprotein Increased |
7.4% |
| Chest Pain |
3.7% |
| Pain |
3.7% |
|
| Weight Decreased |
66.7% |
| Onychoclasis |
33.3% |
|
